Table of Contents
|
|
|
Introduction |
Nutrition, Physical Activity, and Health: An Office-Based Approach |
xxix |
I |
FEEDING THE INFANT |
|
1 |
Infant Nutrition and Development of Gastrointestinal Function |
3 |
|
Development of Gastrointestinal Function |
3 |
|
Development of the Gastrointestinal Tract |
3 |
|
Developmental Disorders |
4 |
|
Development of the Intestinal Epithelium |
5 |
|
Infant Nutrient Assimilation |
6 |
|
Dietary Fats |
7 |
|
Dietary Carbohydrates |
10 |
|
Dietary Protein |
12 |
|
Vitamins and Minerals |
15 |
|
Human Milk |
16 |
|
Intestinal Microbiota in the Infant |
19 |
2 |
Breastfeeding |
29 |
|
Introduction |
29 |
|
Rates of Breastfeeding in the |
29 |
|
The Evidence to Support Breastfeeding |
31 |
|
Contraindications to Breastfeeding |
39 |
|
The Management of Breastfeeding |
40 |
|
Conclusion |
52 |
3 |
Formula Feeding of Term Infants |
61 |
|
General Considerations |
61 |
|
Rates of Breastfeeding and Formula Feeding |
61 |
|
Indications for the Use of Infant Formula |
62 |
|
History of Infant Formula Development |
62 |
|
Rationale for Development of Current Infant Formulas |
63 |
|
Available Forms of Infant Formula |
64 |
|
Infant Formula Labels |
64 |
|
Safe Preparation of Infant Formula |
65 |
|
Safe Handling and Storage of Infant Formula |
67 |
|
Guidelines for Length of Exclusive Formula Feeding and Supplementation with Solid Foods |
68 |
|
Intact Cow Milk Protein-Based Formulas |
69 |
|
Soy Formulas |
72 |
|
Protein Hydrolysate Formulas |
74 |
|
Other Formulas |
76 |
|
Cow Milk |
76 |
4 |
Nutritional Needs of the Preterm Infant |
79 |
|
Energy Requirements |
83 |
|
Protein Amount and Type |
84 |
|
Fats |
84 |
|
Carbohydrates |
85 |
|
Minerals |
86 |
|
Trace Minerals |
88 |
|
Water-Soluble Vitamins |
88 |
|
Fat-Soluble Vitamins |
91 |
|
Energy Density and Water Requirements |
93 |
|
Human Milk |
94 |
|
Facilitating Lactation and Human Milk Handling |
95 |
|
Commercial Formulas for Preterm Infants |
96 |
|
Methods of Enteral Feeding |
97 |
|
Parenteral Nutrition |
99 |
|
Feeding the Preterm Infant After Discharge |
102 |
|
Conclusion |
104 |
5 |
Complementary Feeding |
113 |
|
Introduction |
113 |
|
Infant Growth and Development Factors |
113 |
|
Timing of Complementary Foods Introduction: Review of the Evidence on Related Health Outcomes |
122 |
|
Conclusions: Lack of Evidence to Support or Refute Changing Current Recommendations |
128 |
II |
FEEDING THE CHILD AND ADOLESCENT |
|
6 |
Feeding the Child |
145 |
|
Toddlerhood |
145 |
|
Preschoolers |
147 |
|
School-Aged Children |
148 |
|
Eating Patterns and Nutrient Needs |
149 |
|
Parenting and the Feeding Relationship |
159 |
|
Special Topics |
161 |
|
The Role of Anticipatory Guidance in Promoting Healthy Eating Behaviors |
165 |
7 |
Adolescent Nutrition |
175 |
|
Factors Influencing Nutritional Needs of Adolescents |
175 |
|
Nutrition Concerns During Adolescence |
176 |
|
Nutritional Considerations During Pregnancy |
178 |
|
Nutritional Concerns for Adolescent Bone Health |
179 |
8 |
Cultural Considerations in Feeding Children |
183 |
|
Introduction |
183 |
|
Importance of Addressing Cultural Food Practices |
184 |
|
Understanding Cultural Food Practices: Challenges for Health Care Professionals |
184 |
|
Infant Feeding: Foundation of Eating Behavior |
185 |
|
Young Child Feeding |
190 |
|
Specific Cultural Food Beliefs |
193 |
|
Sources of Advice on Child Feeding |
194 |
9 |
Nutritional Aspects of Vegetarian Diets |
201 |
|
Trends |
203 |
|
Additional Implications of Vegetarianism |
205 |
|
Nutrient Intake Guidelines |
210 |
|
Whole Foods Concept |
210 |
|
Conclusion |
219 |
10 |
Sports Nutrition |
225 |
|
Introduction |
225 |
|
Fueling the Workout |
225 |
|
Building Blocks for Recovery |
230 |
|
Micronutrients |
233 |
|
Determination of Optimal Body Weight in Young Athletes |
235 |
|
Vegetarian Athletes |
239 |
|
Dietary Supplements/Ergogenic Aids |
239 |
11 |
Nutrition During Pregnancy |
249 |
|
Assessment of Nutritional Status |
249 |
|
Guidelines for Gestational Weight Gain |
250 |
|
Nutrient Needs During Pregnancy |
253 |
|
Vitamins |
261 |
|
Alcohol |
264 |
|
Caffeine |
264 |
|
Metabolic Disorders |
264 |
|
Additional Dietary and Lifestyle Concerns |
266 |
12 |
Fast Foods, Organic Foods, Fad Diets |
275 |
|
Fast Food |
275 |
|
Organic Foods |
284 |
|
Fad Diets |
290 |
|
Botanical and Herbal Products |
300 |
III |
MICRONUTRIENTS AND MACRONUTRIENTS |
|
13 |
Energy |
319 |
14 |
Protein |
325 |
|
Recommended Dietary Intake for Protein and Amino Acids |
327 |
|
Methods for Determining Protein and Amino Acid Requirements |
330 |
|
Protein Quality |
332 |
|
Protein Requirements |
334 |
15 |
Carbohydrate and Dietary Fiber |
343 |
|
Digestion of Disaccharides and Starches |
343 |
|
Absorption of Monosaccharides |
343 |
|
Metabolism of Glucose |
344 |
|
Lactose |
346 |
|
Starches |
348 |
|
Fiber |
349 |
|
Current Dietary Recommendations |
353 |
16 |
Fats and Fatty Acids |
357 |
|
General Considerations |
357 |
|
Dietary Fats |
357 |
|
Fat Digestion, Absorption, Transport, and Metabolism |
359 |
|
Essential Fatty Acids |
361 |
|
Long-Chain Polyunsaturated Patty Acids (LCPUFAs) |
364 |
|
Importance of LCPUFAs in Development |
366 |
17 |
Calcium, Phosphorous, and Magnesium |
387 |
|
Basic Physiology/Homeostasis |
387 |
|
Calcium Requirements |
389 |
|
Phosphorous Requirements |
395 |
|
Magnesium Requirements |
396 |
|
Dietary Sources: Calcium and Phosphorous |
397 |
|
Dietary Sources: Magnesium |
398 |
18 |
Iron |
403 |
|
Consequences of Iron Deficiency |
405 |
|
Iron Metabolism and Factors Affecting Iron Balance |
406 |
|
Iron Stores |
406 |
|
Iron Intake and Factors Affecting Iron Absorption |
407 |
|
Iron Loss |
408 |
|
Assessment of Iron Status |
409 |
|
Screening for Iron Deficiency |
410 |
|
Diagnosis of Iron Deficiency |
412 |
|
Specific Recommendations |
413 |
|
Screening and Treatment of Iron-Deficiency Anemia |
417 |
19 |
Trace Elements |
423 |
|
Zinc |
423 |
|
Copper |
431 |
|
Manganese |
435 |
|
Selenium |
438 |
|
Iodine |
441 |
|
Other Trace Elements |
443 |
20 |
Vitamins |
453 |
|
Introduction |
453 |
20-I |
Fat-Soluble Vitamins |
461 |
|
Vitamin A |
461 |
|
Vitamin D |
464 |
|
Vitamin E |
466 |
|
Vitamin K |
468 |
20-II |
Water-Soluble Vitamins |
475 |
|
Thiamine (Vitamin B1) |
476 |
|
Riboflavin (Vitamin B2) |
477 |
|
Niacin (Vitamin B3) |
478 |
|
Pyridoxine (Vitamin B6) |
480 |
|
Cobalamin (Vitamin B12) |
481 |
|
Folate |
483 |
|
Vitamin C |
484 |
|
Other |
485 |
|
Conclusion |
486 |
21 |
New Food Ingredients |
497 |
|
Biotechnology |
497 |
|
Macronutrient Substitutes |
507 |
|
Carbohydrate Replacements |
507 |
|
Fat Replacers |
512 |
IV |
NUTRIENT DELIVERY SYSTEMS |
|
22 |
Parenteral Nutrition |
519 |
|
Catheters |
520 |
|
Composition of Solutions for Infants and Children |
523 |
|
Ordering Parenteral Nutrition |
532 |
|
Gastrointestinal and Hepatic Effects of. Parenteral Nutrition |
534 |
|
Compatibilities |
535 |
|
Transition to Enteral Feedings |
535 |
|
Conclusion |
536 |
23 |
Enteral Nutrition |
541 |
|
Indications for Enteral Tube Feedings: Management of Nutrition-Related Disorders |
541 |
|
Enteral Formula Selection for Children 1 to 10 Years of Age |
547 |
|
Formulas for Use in Children Older than 10 Years of Age: Standard Tube-Feeding Formulas |
548 |
|
Peptide-Based and Elemental Formulas |
549 |
|
Oral Supplements |
549 |
|
Blenderized Formulas |
550 |
|
Formula Concentration and Supplementation with Use of Modular Components |
551 |
|
Tube Feeding |
552 |
|
Continuous versus Intermittent Feeding |
554 |
|
One Final Note |
554 |
V |
NUTRITION IN ACUTE AND CHRONIC ILLNESS |
|
24 |
Assessment of Nutritional Status |
559 |
|
Assessment by History |
559 |
|
Clinical Assessment |
559 |
|
Anthropometry |
560 |
|
BMT |
564 |
|
Head Circumference |
564 |
|
Mid-Arm Circumference |
564 |
|
Mid-Arm Circumference-to-Head Circumference Ratio |
565 |
|
Nutritional Assessment Through the Measurement of Body Composition |
565 |
|
Fat-Fold Measurement |
566 |
|
Hydrodensitomentry |
567 |
|
Air-Displacement Plethysmographv |
568 |
|
Total Body Potassium |
568 |
|
Total Body Water |
569 |
|
Neutron Activation |
569 |
|
Photon and X-ray Absorptiometry |
570 |
|
Bioelectrical Impedance Analysis |
570 |
|
Total Body Electrical Conductivity |
571 |
|
Laboratory Assessment |
571 |
25 |
Pediatric Feeding and Swallowing Disorders |
577 |
|
Introduction |
577 |
|
Ccmmon Conditions Associated with Swallowing Disorders |
577 |
|
Deferential Diagnosis of Feeding versus Swallowing Disorders |
578 |
|
Feeding Disorders |
579 |
|
Swallowing Disorders |
582 |
|
Evaluation of Pediatric Dysphagia |
585 |
|
Treatment |
588 |
|
Current Trends and Perspectives in Pediatric Feeding and Swallowing Disorders |
590 |
|
Conclusion |
594 |
26 |
Failure to Thrive |
601 |
|
Ecologic Context |
601 |
|
Medical Issues in Evaluation and Treatment |
603 |
|
Nutritional Evaluation and Treatment |
615 |
|
Psychosocial Issues in Evaluation and Treatment |
623 |
|
Intervention |
625 |
|
Conclusion |
628 |
27 |
Chronic Diarrheal Disease |
637 |
|
Introduction and Pathophysiology |
637 |
|
Evaluation of the Infant and Child Aid: Persistent Diarrhea |
638 |
|
Differential Diagnosis of Persistent Diarrhea |
641 |
|
Summary |
648 |
28 |
Oral Therapy for Acute Diarrhea |
651 |
|
Physiological Principles |
651 |
|
The Search for a More Effective ORS |
653 |
|
Early, Appropriate Feeding |
654 |
|
Oral Therapy for Diarrhea |
654 |
|
Common Concerns About ORS in the
|
657 |
29 |
Inborn Errors of Metabolism |
661 |
|
Definitions |
661 |
|
Inheritance |
661 |
|
Newborn Screening |
661 |
|
Signs and Symptoms of an IEM |
662 |
|
Emergency Therapy for a Suspected IEM |
663 |
|
Nutritional Therapy Using Synthetic Medical Roods |
664 |
|
Other Nutritional Therapies |
666 |
|
Other Therapeutic Modalities |
669 |
|
Conclusion |
671 |
30 |
Dietary Management of Diabetes Mellitus in Children |
673 |
|
Type 1 Diabetes Mellitus |
673 |
|
Type 2 Diabetes Mellitus |
693 |
31 |
Hypoglycemia in Infants and Children |
701 |
|
Introduction and Definition of Hypoglycemia |
701 |
|
Clinical Manifestations of Hypoglycemia |
703 |
|
Etiology of Hypoglycemia |
704 |
|
Evaluation of Hypoglycemia |
706 |
|
Differential Diagnosis of Hypoglycemia |
703 |
|
Treatment |
711 |
32 |
Hyperlipidemia and Prevention of Cardiovascular Disease |
719 |
|
Lipoproteins |
720 |
|
Types of Hyperlipidemia |
721 |
|
Prevention of Atherosclerosis and Prudent Lifestyle and Diet |
723 |
|
Screening for Hyperlipidemia |
724 |
|
Treatment |
729 |
33 |
Pediatric Obesity |
733 |
|
Definition and Epidemiology |
733 |
|
Pathophysiology |
740 |
|
Systems Integrating Energy Intake and Energy Expenditure: Physiology and Molecular Genetics |
742 |
|
Clinical and Laboratory Correlates of Obesity in Children |
752 |
|
Identification of the Obese Child and Decisions Regarding Therapeutic Intervention |
755 |
|
Treatment of the Obese Child |
759 |
34 |
Food Sensitivity |
783 |
|
Definitions |
783 |
|
Diagnosis of Food Hypersensitivity |
785 |
|
Food Sensitivity Not involving IgE Antibody |
792 |
|
Milk Allergy |
793 |
|
Treatment |
793 |
|
Prognosis |
794 |
|
Prevention |
795 |
35 |
Nutrition and Immunity |
801 |
|
Introduction |
801 |
|
Early Nutritional-Immunologic System Interactions |
802 |
|
Preterm Birth and Infants with Low Birth Weight |
807 |
|
Micronutrients and Immunity |
807 |
|
Summery |
812 |
36 |
Nutritional Support for Children with Developmental Disabilities |
821 |
|
Introduction |
821 |
|
Growth Abnormalities in Children with Neurologic Impairments |
821 |
|
Asseismenr |
825 |
|
Nutritional Intervention |
829 |
|
Conclusion |
837 |
37 |
Nutrition of Children Who are Critically III |
843 |
|
Metabolic reserves and Baseline Requirements |
843 |
|
Protein Metabolism |
844 |
|
Energy Metabolism |
846 |
|
Carbohydrate Metabolism |
847 |
|
Lipid Metabolism |
843 |
|
Vitamin and Trace Mineral Metabolism |
850 |
|
Routes of Nutrient Provision |
850 |
|
Conclusion |
851 |
38 |
Anorexia Nervosa and Bulimia Nervosa |
855 |
|
Clinical Features |
855 |
|
Assessment |
859 |
39 |
Nutrition of Children with HIV-1 Infection |
875 |
|
Wasting Syndrome |
875 |
|
Causes of Malnutrition in HIV and AIDS |
878 |
|
The Nutritional Effects of HAAKT |
884 |
|
Recommendations for Nutritional Support |
886 |
|
Conclusion |
890 |
40 |
Nutrition for Children with Sickle Cell Disease |
901 |
41 |
Nutritional Management of Children with Renal Disease |
905 |
|
Introduction |
905 |
|
Urinary Tract Infections, Vesicoureteral Reflux, and Urinary Incontinence |
905 |
|
Hypertension |
909 |
|
Kidney Stone Disorders |
911 |
|
Renal Tubular Defects |
912 |
|
Nephrotic Syndrome |
913 |
|
Glomerulonephritis |
915 |
|
Acute Renal Failure |
915 |
|
Chronic Renal Failure |
917 |
|
Vitamins and Trace Mineral? |
919 |
|
Children on Dialysis |
920 |
|
Renal Transplantation |
920 |
42 |
Nutritional Management of Children with Cancer |
927 |
|
Nutritional Status at Diagnosis |
927 |
|
Host-Related Effects on Nutritional Status |
927 |
|
Therapy-Related Effects on Nutritional Status |
928 |
|
Physiological Factors |
929 |
|
Nutritional Screening |
930 |
|
Nutritional Assessment |
930 |
|
Nutrition Therapy |
933 |
|
Tube Feeding |
934 |
|
Parenteral Nutrition |
936 |
|
The Relationship Between Diet and Cancer |
936 |
43 |
Inflammatory Bowel Disease |
941 |
|
Growth Failure |
941 |
|
Role of Cytokines and Endocrine Mediators |
941 |
|
Monitoring of Nutritional Status |
942 |
|
Nutritional Therapy for IBD |
949 |
|
Psychosocial Effects of Nutritional Interventions in the Cars of Children with LED |
953 |
|
Summary |
955 |
44 |
Liver Disease |
959 |
|
Nutritional Assessment of the Child with Liver Disease |
961 |
|
Malabsorption in Chronic Liver Disease |
963 |
|
Ascites Management |
974 |
|
Liver Failure |
975 |
|
Parenteral Nutrition-Associated Liver Disease |
977 |
45 |
Cardiac Disease |
981 |
|
Undernutrition in CHD |
982 |
|
Energy Expenditure |
982 |
|
Nutrient Losses |
983 |
|
Nutrient Intake |
984 |
|
Congestive Heart failure |
985 |
|
Cyan one Heart Disease |
986 |
|
Circulatory Shunts |
986 |
|
Pulmonary Hypertension |
987 |
|
Surgery |
987 |
|
Nutritional Assessment |
983 |
|
Nutritional Support |
988 |
|
Nutrient Prescription |
989 |
|
Feeding Strategies |
994 |
|
Monitoring Outcome |
996 |
46 |
Nutrition in Cystic Fibrosis |
1001 |
|
Diagnosis |
1001 |
|
Assessment of Pancreatic Function Status |
1003 |
|
Nutritional Care |
1004 |
|
Specific Guidelines |
1007 |
|
Commonly Encountered Nutritional Problems |
1009 |
|
Enzyme Therapy |
1012 |
|
Vitamin Therapy |
1016 |
47 |
The Ketogenic Diet |
1021 |
|
History |
1021 |
|
Physiological Basis |
1021 |
|
Mechanisms of Action |
1024 |
|
Indications |
1024 |
|
Efficacy |
1025 |
|
Contraindications |
1026 |
|
Adverse Streets |
1028 |
|
The Keto Team |
1029 |
|
Calculation of the Ketogenic Diet |
1029 |
|
Micronutrient Supplementation |
1031 |
|
Injection Protocol |
1032 |
|
Maintenance and Follow-Up |
1033 |
|
Concurrent Medications and Occur Carbohydrates |
1033 |
|
Adjusting the Diet for Optima! Seizure Control |
1034 |
|
Discontinuation of the Ketogenic Diet |
1034 |
|
Alternative Dietary Therapy |
1035 |
|
Conclusions |
1035 |
48 |
Nutrition and Oral Health |
1041 |
|
Introduction |
1041 |
|
Dental Caries—An Infectious Disease |
1041 |
|
Dietary Influences |
1042 |
|
The Costs are Enormous |
1045 |
|
Nutritional Effects |
1046 |
|
Fluoride Background |
1046 |
|
Fluoride Supplements |
1047 |
|
Fluorosis |
1049 |
|
Fluoride Toxicity |
1051 |
|
Role of the Pediatrician |
1052 |
49 |
Community Nutrition Services |
1057 |
|
Nutrition Services Provided through Federal, State and Local Health and Nutrition Agencies |
1057 |
|
Health and Nutrition Agencies a Nutrition Resource to Provide Service and Identify Qualified Providers |
1059 |
|
Nutrition-Assistance Programs |
1064 |
|
Supplemental Food Programs |
1069 |
|
Food Distribution Programs |
1072 |
|
Where to Seek Nutrition Assistance for Clients |
1074 |
|
Other Federal Agencies Providing Nutrition Services to Improve Pediatric Health and Well-Hew? |
1075 |
|
Conclusion |
1077 |
50 |
Food Labeling |
1079 |
|
Ingredient Labeling |
1079 |
|
The Nutrition Facts Panel |
1080 |
|
Nutrition Claims |
1085 |
|
Health Claims |
1085 |
|
Juice Labeling |
1088 |
|
Package Dating |
1088 |
|
Conclusion |
1089 |
51 |
Current Legislation and Regulations for Infant Formulas |
1091 |
52 |
Food Safety: Infectious Disease |
1095 |
|
Introduction |
I095 |
|
Epidemiology of Foodborne Disease |
1096 |
|
Clinical Manifestations, Diagnosis, and Treatment |
1100 |
|
Surveillance for Foodborne Diseases |
1103 |
|
Prevention |
1105 |
53 |
Food Safety: Pesticides, Industrial Chemicals, Toxins, Antimicrobial Preservatives and Irradiation, and Indirect Food Additives |
1117 |
|
Introduction |
1117 |
|
Sources of Concern for Chemical Food Safety |
1119 |
|
Food Irradiation |
1128 |
|
Nonnutritive Additives |
1133 |
|
APPENDICES |
|
|
Appendix A |
1143 |
Table A-1 |
Exchange Lists for Diabetic Diets |
1145 |
Table A-2 |
food Exchange Lists |
1145 |
|
Appendix B |
1167 |
Table B-1 |
Conversions From Conventional Units to Systems International (SI) Units |
1169 |
|
Appendix C |
1199 |
Table C-1 |
Representative Value; for Constituents of Human Milk |
1201 |
|
Appendix D |
1205 |
Table D-1 |
CDC Growth Chats |
1207 |
Table D-2 |
WHO Growth Charts |
1225 |
Table D-3 |
Low Birth Weight and Intrauterine Growth Charts |
1223 |
Table D-4 |
Arm Measurements |
1238 |
|
Appendix E |
1243 |
Table E-1 |
Recommended Nutrient Levels of Infant Formulas |
1245 |
|
Appendix F |
1247 |
Table F-1 |
Increasing the Caloric Density of Infant Formula |
1249 |
Table F-2 |
Cow Milk-Eased Infant Formulas: Label Claim Nutrient Contents |
1250 |
Table F-3 |
Soy-Based Infant Formulas: Label Claim Nutrient Contents. |
1259 |
Table F-4 |
Selected Nutrients in Human Milk, Various Forms of Cow Milk, and Goat Milk |
1265 |
|
Appendix G |
1267 |
Table G-1 |
Extensively Hydrolyzed Protein-Based and Amino Acid-Based Formulas for Infants: Label Claim Nutrient Contents |
1269 |
|
Appendix H |
1273 |
Table H-1 |
Milk-Based Follow-up Infant Formulas: Label Claim Nutrient Contents |
1275 |
Table H-2 |
Soy Follow-up Infant Formulas- Label Claim Nutrient Contents |
1279 |
|
Appendix I |
1283 |
Table I-1 |
Formulas for Infants With Low Birth Weight and Preterm Infants |
1235 |
Table 1-2 |
Nutrients Provided by Human Milk Fortifiers for Preterm Infants Fed Human Milk |
1263 |
|
Appendix J |
1291 |
Table J-1 |
Dietary Reference intakes Recommended Intakes for individual |
1294 |
Table J-2 |
Dietary Reference Intakes: Tolerable Upper Intake Levels |
1297 |
Table J-3 |
Nutrition During Pregnancy |
1300 |
|
Appendix K |
1303 |
Fig K-1 |
MyPyramid |
1305 |
Fig K-2 |
MyPyramid for Kids |
1306 |
Fig K-3 |
MyPyramid Enjoy Moving |
1303 |
|
Appendix L |
1309 |
Table L-1 |
Beverages and Alcoholic Drinks Calories and Selected Electrolytes |
1311 |
|
Appendix M |
1313 |
Table M-1 |
Carbohydrate Content of Juices |
1315 |
|
Appendix N |
1317 |
Table N-1 |
Drugs for Which Absorption Is Increased by Food |
1319 |
Table N-2 |
Drugs for Which Absorption May Be Delayed by Food or Milk |
1320 |
Table N-3 |
Drugs That Should be Administered on an Empty Stomach |
1321 |
Table N-4 |
Miscellaneous Food-Nutrient Effects |
1322 |
Table N-5 |
Drug-Grapefruit Juice Interactions |
1324 |
|
Appendix O |
1327 |
Table O-1 |
Review of Fad Diets and Other Popular Weight-Loss Diets |
1329 |
|
Appendix P |
1339 |
Table P-1 |
Sources of Dietary-Fiber |
1341 |
Table P-2 |
Available Over-the-Counter Preparations of Fiber |
1345 |
|
Appendix Q |
1347 |
Table Q-1 |
Approximate Calcium Contents of 1 Serving of Some Common Foods That Are Good Sources of Calcium |
1349 |
Table Q-2 |
Calcium Content of Foods |
1351 |
|
Appendix R |
1353 |
Table R-1 |
Iron Content of Selected Foods |
1355 |
|
Appendix S |
1357 |
Table S-1 |
Zinc Content of Common Household Portions of Selected Foods |
1359 |
|
Appendix T |
1361 |
Table T-1 |
Commercially Available Parenteral Nutrition Solutions |
1363 |
|
Appendix U |
1365 |
Table U-1 |
Enteral Products for Special Indications |
1367 |
Table U-2 |
Enteral Products Grouped by Usage Indication |
1385 |
Table U-3 |
Sources of Medical Food Modules for Treatment of Inborn Errors of Metabolism |
1387 |
|
Appendix V |
1391 |
Table V-1 |
Sports/Nutrition Bars |
1393 |
|
Appendix W |
1395 |
Table W-1 |
Mid-Upper Arm Circumference for Length or Height Reference Data |
1397 |
Table W-2 |
Mid-Upper Arm Circumference for Age Reference Data for Boys Aged 6- 59 Months |
1407 |
Table W-3 |
Mid-Upper Arm Circumference for Age Reference Data for Girls Aged 6-59 Months |
1411 |
|
Appendix X |
1415 |
Table X-1 |
Saturated and Polyunsaturated Fat and Cholesterol Content of Common Foods |
1417 |
|
Appendix Y |
1421 |
Table Y-1 |
Sodium Content of Foods |
1423 |
|
Index |
1425 |
|
|
|